Paolo Paoletti, CEO of GammaDelta Therapeutics celebrated in the 2019 Maserati 100 Innovators of the year award.

News

GammaDelta Therapeutics will be keeping the global community updated with news about their pioneering research and development for the exploitation of tissue derived γδ T cells.

Press Release 25th Mar 2019

Paolo Paoletti, CEO of GammaDelta Therapeutics celebrated in the 2019 Maserati 100 Innovators of the year award.

Press Release 20th Dec 2018

GammaDelta Therapeutics to move to London’s White City life sciences cluster

News 12th Oct 2018

GammaDelta Therapeutics announced as winner of the 2018 Outstanding Achievement Award at the OBN Annual Awards Ceremony.

Press Release 21st Jun 2018

GammaDelta Therapeutics Appoints Michael Koslowski as CMO

Press Release 12th Jun 2018

GammaDelta Therapeutics acquires Lymphact to advance their gamma delta (γδ) T-Cell platform into the clinic

News 18th Jan 2018

GammaDelta featured in The Endpoints 11

News 11th Jan 2018

GammaDelta Therapeutics named as one of the top European biotech companies to watch in 2018

News 17th Nov 2017

GammaDelta Therapeutics Q&A Session with Raj Mehta

News 26th Oct 2017

GammaDelta Therapeutics highlighted in press release by the Treasury announcing new investment into the UK life science sector

News 7th Oct 2017

GammaDelta Therapeutics highlighted in CNBC Europe News

News 7th Aug 2017

Betting big on Gamma Delta T Cells

News 12th Jun 2017

This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK

News 19th May 2017

GammaDelta’s Scientific Co-Founder Adrian Hayday Receives Inaugural Business of Science Leadership Award

Press Release 9th May 2017

Takeda and GammaDelta Therapeutics Announce Collaboration to Advance Tissue-derived gamma delta (γδ) T Cells

Press Release 3rd May 2017

GammaDelta Therapeutics expands management team led by Paolo Paoletti as CEO